Report cover image

Long-Acting Contraceptive Pills Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 06, 2025
Length 119 Pages
SKU # APRC20261022

Description

Summary

According to APO Research, the global Long-Acting Contraceptive Pills market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Long-Acting Contraceptive Pills is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Long-Acting Contraceptive Pills include Bayer, Cipla, Merck, Sun Pharma, Teva Pharmaceuticals, Pfizer, Mylan, Shanghai Pharmaceuticals and Zhejiang Xianju Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-Acting Contraceptive Pills, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Contraceptive Pills.

The report will help the Long-Acting Contraceptive Pills manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Long-Acting Contraceptive Pills market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-Acting Contraceptive Pills market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Long-Acting Contraceptive Pills Segment by Company

Bayer
Cipla
Merck
Sun Pharma
Teva Pharmaceuticals
Pfizer
Mylan
Shanghai Pharmaceuticals
Zhejiang Xianju Pharmaceutical
Long-Acting Contraceptive Pills Segment by Type

Injectables
Subdermal Implants
Intrauterine Devices
Other
Long-Acting Contraceptive Pills Segment by Application

Hospital
Clinic
Long-Acting Contraceptive Pills Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Acting Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long-Acting Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Acting Contraceptive Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Long-Acting Contraceptive Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Long-Acting Contraceptive Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Long-Acting Contraceptive Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

119 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Long-Acting Contraceptive Pills Market Size (2020-2031)
2.2.2 Global Long-Acting Contraceptive Pills Sales (2020-2031)
2.2.3 Global Long-Acting Contraceptive Pills Market Average Price (2020-2031)
2.3 Long-Acting Contraceptive Pills by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Injectables
2.3.3 Subdermal Implants
2.3.4 Intrauterine Devices
2.3.5 Other
2.4 Long-Acting Contraceptive Pills by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
3.1 Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Long-Acting Contraceptive Pills Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Long-Acting Contraceptive Pills Revenue of Manufacturers (2020-2025)
3.4 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2020-2025)
3.5 Global Long-Acting Contraceptive Pills Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Long-Acting Contraceptive Pills, Product Type & Application
3.8 Global Manufacturers of Long-Acting Contraceptive Pills, Established Date
3.9 Global Long-Acting Contraceptive Pills Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Bayer
4.1.1 Bayer Company Information
4.1.2 Bayer Business Overview
4.1.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
4.1.5 Bayer Recent Developments
4.2 Cipla
4.2.1 Cipla Company Information
4.2.2 Cipla Business Overview
4.2.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
4.2.5 Cipla Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Merck Long-Acting Contraceptive Pills Product Portfolio
4.3.5 Merck Recent Developments
4.4 Sun Pharma
4.4.1 Sun Pharma Company Information
4.4.2 Sun Pharma Business Overview
4.4.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
4.4.5 Sun Pharma Recent Developments
4.5 Teva Pharmaceuticals
4.5.1 Teva Pharmaceuticals Company Information
4.5.2 Teva Pharmaceuticals Business Overview
4.5.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
4.5.5 Teva Pharmaceuticals Recent Developments
4.6 Pfizer
4.6.1 Pfizer Company Information
4.6.2 Pfizer Business Overview
4.6.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
4.6.5 Pfizer Recent Developments
4.7 Mylan
4.7.1 Mylan Company Information
4.7.2 Mylan Business Overview
4.7.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
4.7.5 Mylan Recent Developments
4.8 Shanghai Pharmaceuticals
4.8.1 Shanghai Pharmaceuticals Company Information
4.8.2 Shanghai Pharmaceuticals Business Overview
4.8.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
4.8.5 Shanghai Pharmaceuticals Recent Developments
4.9 Zhejiang Xianju Pharmaceutical
4.9.1 Zhejiang Xianju Pharmaceutical Company Information
4.9.2 Zhejiang Xianju Pharmaceutical Business Overview
4.9.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
4.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
5 Global Long-Acting Contraceptive Pills Market Scenario by Region
5.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Long-Acting Contraceptive Pills Sales by Region: 2020-2031
5.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2020-2025
5.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2026-2031
5.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2020-2031
5.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2020-2025
5.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2026-2031
5.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
5.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2020-2031)
5.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
5.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2020-2031)
5.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Country
5.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Country (2020-2031)
5.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Long-Acting Contraceptive Pills Market Facts & Figures by Country
5.7.1 South America Long-Acting Contraceptive Pills Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Long-Acting Contraceptive Pills Sales by Country (2020-2031)
5.7.3 South America Long-Acting Contraceptive Pills Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
5.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2020-2031)
5.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Long-Acting Contraceptive Pills Sales by Type (2020-2031)
6.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2020-2031) & (K Units)
6.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2020-2031)
6.2 Global Long-Acting Contraceptive Pills Revenue by Type (2020-2031)
6.2.1 Global Long-Acting Contraceptive Pills Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2020-2031)
6.3 Global Long-Acting Contraceptive Pills Price by Type (2020-2031)
7 Segment by Application
7.1 Global Long-Acting Contraceptive Pills Sales by Application (2020-2031)
7.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2020-2031) & (K Units)
7.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2020-2031)
7.2 Global Long-Acting Contraceptive Pills Revenue by Application (2020-2031)
7.2.1 Global Long-Acting Contraceptive Pills Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2020-2031)
7.3 Global Long-Acting Contraceptive Pills Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Long-Acting Contraceptive Pills Value Chain Analysis
8.1.1 Long-Acting Contraceptive Pills Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Long-Acting Contraceptive Pills Production Mode & Process
8.2 Long-Acting Contraceptive Pills Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Long-Acting Contraceptive Pills Distributors
8.2.3 Long-Acting Contraceptive Pills Customers
9 Global Long-Acting Contraceptive Pills Analyzing Market Dynamics
9.1 Long-Acting Contraceptive Pills Industry Trends
9.2 Long-Acting Contraceptive Pills Industry Drivers
9.3 Long-Acting Contraceptive Pills Industry Opportunities and Challenges
9.4 Long-Acting Contraceptive Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.